| # | Title | Journal | Year | Citations |
|---|
| 1 | Evolving importance of kidney disease: from subspecialty to global health burden | Lancet, The | 2013 | 874 |
| 2 | SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis | Lancet Diabetes and Endocrinology,the | 2019 | 595 |
| 3 | Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward | Kidney International | 2014 | 565 |
| 4 | Chronic kidney disease | Nature Reviews Disease Primers | 2017 | 558 |
| 5 | Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children | Canadian Journal of Cardiology | 2018 | 474 |
| 6 | Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study | The Lancet Child and Adolescent Health | 2017 | 453 |
| 7 | Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference | Kidney International | 2020 | 407 |
| 8 | Chronic Kidney Disease and Coronary Artery Disease | Journal of the American College of Cardiology | 2019 | 403 |
| 9 | Sirolimus Is Associated with New-Onset Diabetes in Kidney Transplant Recipients | Journal of the American Society of Nephrology: JASN | 2008 | 365 |
| 10 | Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children | Canadian Journal of Cardiology | 2020 | 324 |
| 11 | Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency | American Journal of Kidney Diseases | 2020 | 311 |
| 12 | Magnesium Deficiency: Pathophysiologic and Clinical Overview | American Journal of Kidney Diseases | 1994 | 293 |
| 13 | Assessment of Global Kidney Health Care Status | JAMA - Journal of the American Medical Association | 2017 | 282 |
| 14 | Evaluating a New International Risk-Prediction Tool in IgA Nephropathy | JAMA Internal Medicine | 2019 | 266 |
| 15 | Variability and Risk Factors for Kidney Disease Progression and Death Following Attainment of Stage 4 CKD in a Referred Cohort | American Journal of Kidney Diseases | 2008 | 240 |
| 16 | THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Clinical Epidemiology of Cardiovascular Disease in Chronic Kidney Disease Prior to Dialysis | Seminars in Dialysis | 2003 | 224 |
| 17 | Screening for renal disease using serum creatinine: who are we missing? | Nephrology Dialysis Transplantation | 2001 | 218 |
| 18 | Central Vein Stenosis: A Common Problem in Patients on Hemodialysis | ASAIO Journal | 2005 | 216 |
| 19 | Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups | Circulation | 2019 | 211 |
| 20 | Arteriovenous fistula-associated high-output cardiac failure: a review of mechanisms | American Journal of Kidney Diseases | 2004 | 202 |
| 21 | Treatment of Polyomavirus Infection in Kidney Transplant Recipients: A Systematic Review | Transplantation | 2010 | 196 |
| 22 | The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics | American Journal of Nephrology | 2017 | 194 |
| 23 | Cardiovascular disease in patients with chronic kidney disease: Getting to the heart of the matter | American Journal of Kidney Diseases | 2001 | 193 |
| 24 | Hypertension in infancy: diagnosis, management and outcome | Pediatric Nephrology | 2012 | 190 |
| 25 | Survival among nocturnal home haemodialysis patients compared to kidney transplant recipients | Nephrology Dialysis Transplantation | 2009 | 172 |
| 26 | The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation | Kidney International | 2005 | 164 |
| 27 | Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis | Kidney International | 2012 | 159 |
| 28 | Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference | Kidney International | 2021 | 156 |
| 29 | Small Acute Increases in Serum Creatinine Are Associated with Decreased Long-Term Survival in the Critically Ill | American Journal of Respiratory and Critical Care Medicine | 2014 | 155 |
| 30 | Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial | Lancet Diabetes and Endocrinology,the | 2020 | 155 |
| 31 | Vitamin D and its analogues: Do they protect against cardiovascular disease in patients with kidney disease? | Kidney International | 2005 | 149 |
| 32 | Outcomes of Kidney Transplantation From Older Living Donors to Older Recipients | American Journal of Kidney Diseases | 2008 | 146 |
| 33 | Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events | Kidney International | 2016 | 139 |
| 34 | Risk Stratification of Patients With IgA Nephropathy | American Journal of Kidney Diseases | 2012 | 137 |
| 35 | Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey | BMJ: British Medical Journal | 2019 | 131 |
| 36 | Cardiovascular Disease and Hypertension Risk in Living Kidney Donors: An Analysis of Health Administrative Data in Ontario, Canada | Transplantation | 2008 | 126 |
| 37 | Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system | Kidney International Supplements | 2018 | 123 |
| 38 | Nephrectomy After Transplant Failure: Current Practice and Outcomes | American Journal of Transplantation | 2007 | 116 |
| 39 | Use of GFR equations to adjust drug doses in an elderly multi-ethnic group a cautionary tale | Nephrology Dialysis Transplantation | 2007 | 115 |
| 40 | Improving outcomes of acute kidney injury: report of an initiative | Nature Clinical Practice Nephrology | 2007 | 112 |
| 41 | Vitamin D deficiency and anemia in early chronic kidney disease | Kidney International | 2010 | 112 |
| 42 | Sex, haemoglobin and kidney disease: new perspectives | European Journal of Clinical Investigation | 2005 | 110 |
| 43 | Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease | Kidney International | 2013 | 106 |
| 44 | Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial | Journal of the American Society of Nephrology: JASN | 2020 | 106 |
| 45 | Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference | Kidney International | 2021 | 103 |
| 46 | The importance of transitions between dialysis and transplantation in the care of end-stage renal disease patients | Kidney International | 2007 | 99 |
| 47 | Clinical Practice Guidelines and Recommendations on Peritoneal Dialysis Adequacy 2011 | Peritoneal Dialysis International | 2011 | 97 |
| 48 | The Long-Term Quality of Life of Living Kidney Donors: A Multicenter Cohort Study | American Journal of Transplantation | 2011 | 95 |
| 49 | Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7% | Circulation | 2020 | 95 |
| 50 | Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice | Kidney International | 2021 | 93 |
